R&D shuffle at AstraZeneca
This article was originally published in Scrip
Executive Summary
AstraZeneca's R&D head Dr Martin Mackay has brought in his old Pfizer colleague Dr Briggs Morrison as executive vice-president of global medicines development, replacing Dr Anders Ekblom.